Skip to main content

Table 6 Multivariate analysis for overall survival including disease stage

From: Serial detection of circulating tumour cells by reverse transcriptase-polymerase chain reaction assays is a marker for poor outcome in patients with malignant melanoma

Marker

Hazard Ratio

95% CI

P

Sex

1.013

0.46–2.19

0.973

Age

1.011

0.98–1.04

0.480

AJCC Stage (I-III)

2.907

1.24–6.81

0.014

CMC status (0–1 vs ≥2 positive assays)

2.468

1.12–6.23

0.037

  1. CI, confidence interval